Quick Takeaways
- L1 Capital Global Opportunities Master Fund, Ltd. filed SCHEDULE 13G/A for Helius Medical Technologies, Inc. Common Stock, $0.001 par value per share (HSDT).
- Disclosed ownership: 1%.
- Date of event: 14 Aug 2025.
L1 Capital Global Opportunities Master Fund, Ltd. - 14 Aug 2025 SCHEDULE 13G/A Report for Helius Medical Technologies, Inc. Common Stock, $0.001 par value per share (HSDT)
- Filing Manager
- L1 Capital Global Opportunities Master Fund, Ltd.
- Reporting Manager
- L1 Capital Global Opportunities Master Fund, Ltd.
- Symbol
- HSDT
- Shares outstanding
- 63,366 shares
- Disclosed Ownership
- 640 shares
- Ownership
- 1%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Aug 2025, 19:08:10 UTC
- Date of event
- 14 Aug 2025
- Previous filing
- 13 Jun 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"L1 Capital Global Opportunities Master Fund, Ltd. disclosed 1% ownership in Helius Medical Technologies, Inc. Common Stock, $0.001 par value per share (HSDT) on 14 Aug 2025."
What Changed
- Previous schedule filing date: 13 Jun 2025.
- Current filing was accepted on 14 Aug 2025, 19:08.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| L1 Capital Global Opportunities Master Fund, Ltd. | 1% | 640 | 640 | 0 | /s/ David Feldman | David Feldman, Director |